🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2024-08-01
Trial ID
NCT06216249
This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-06
Trial ID
NCT07219147
This retrospective observational study will evaluate high-dose methotrexate...
Status
Unknown
Location
Assistance Publique Hôpitaux de Marseille (APHM), La Timone Hospital
Start Date
2022-04-01
Trial ID
NCT05899751
Treatments Being Tested
This early phase I trial studies how well glucarpidase works in reducing to...
Status
Completed
Location
Mayo Clinic in Florida
Start Date
2019-03-27
Trial ID
NCT03960177
Treatments Being Tested
The purpose of this study is to demonstrate whether use of glucarpidase fac...
Status
Terminated
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00634322
Treatments Being Tested
This phase II trial studies how well prostate specific membrane antigen (PS...
Status
Recruiting
Location
University of Pittsburgh Cancer Institute (UPCI)
Start Date
2020-09-30
Trial ID
NCT04175431
This phase II trial compares the usual treatment of radiation therapy alone...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2022-04-20
Trial ID
NCT05053152
This protocol is for the treatment of toxic plasma methotrexate concentrati...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00481559
Treatments Being Tested
Primary Objectives: 1. To evaluate the efficacy of Glucarpidase (Voraxaze)...
Status
Terminated
Location
U.T. M.D. Anderson Cancer Center
Start Date
2007-01
Trial ID
NCT00424645
Treatments Being Tested
This phase II trial tests how well golimumab and apalutamide work in treati...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2024-05-23
Trial ID
NCT05960578